Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study

被引:1
|
作者
Hannawi, Suad [1 ]
Zhang, Rong-Rong [2 ]
Abuquta, Alaa [3 ]
Safeldin, Linda [4 ]
Hassan, Aala [4 ]
Alamadi, Ahmad [4 ]
Hossain, Tasmiah [4 ]
Mostafa, Mohamed [5 ]
Ghoneim, Yasser [5 ]
Solo, Jennifer [5 ]
Zheng, Hong-Xia [6 ]
Wu, Ding-Feng [6 ]
Yu, Dan-Dan [6 ]
Yuan, Jia-Cheng [6 ]
Zhao, Di [6 ]
Lin, Rui [6 ]
Ying, Bo [6 ,8 ]
Qin, Cheng-Feng [2 ,7 ]
机构
[1] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Internal Med Dept, Emirates Hlth Serv EHS, Dubai, U Arab Emirates
[2] Acad Mil Med Sci AMMS, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China
[3] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Accid & Emergency Dept, EHS, Dubai, U Arab Emirates
[4] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Gen Surg Dept, EHS, Dubai, U Arab Emirates
[5] PDC FZ LLC, Contract Res Org, Dubai, U Arab Emirates
[6] Suzhou Abogen Biosci Co Ltd, Abogen Biosci, Suzhou, Peoples R China
[7] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
[8] Suzhou Abogen Biosci Co Ltd, Abogen Biosci, Suzhou 215123, Peoples R China
来源
CLINICAL AND TRANSLATIONAL MEDICINE | 2023年 / 13卷 / 08期
关键词
D O I
10.1002/ctm2.1387
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Effectiveness of first-generation severe acute respiratory syndrome coronavirus 2 mRNA vaccines against the Omicron variant
    Dagan, Noa
    Barda, Noam
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (12) : 1526 - 1527
  • [22] Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine
    Leung, Nancy H. L.
    Cheng, Samuel M. S.
    Martin-Sanchez, Mario
    Au, Niki Y. M.
    Ng, Yvonne Y.
    Luk, Leo L. H.
    Chan, Karl C. K.
    Li, John K. C.
    Leung, Yonna W. Y.
    Tsang, Leo C. H.
    Chaothai, Sara
    Kwan, Kelvin K. H.
    Ip, Dennis K. M.
    Poon, Leo L. M.
    Leung, Gabriel M.
    Peiris, J. S. Malik
    Cowling, Benjamin J.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E299 - E307
  • [23] An open-label, single-arm, phase I study to evaluate the safety and immunogenicity of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, in healthy adult volunteers
    Namhee Kim
    Gyoungjin Choi
    Chi-Yeon Lim
    Jae-Won Lee
    Kyung-Hyo Kim
    Hoan Jong Lee
    Archives of Pharmacal Research, 2010, 33 : 919 - 924
  • [24] Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study
    Loebermann, M.
    Anders, G.
    Brestrich, G.
    Fritzsche, C.
    Klammt, S.
    Borso, D.
    Frimmel, S.
    Riebold, D.
    Reisinger, E. C.
    VACCINE, 2011, 29 (06) : 1228 - 1234
  • [25] An Open-label, Single-arm, Phase I Study to Evaluate the Safety and Immunogenicity of LBVH0101, a New Haemophilus influenzae Type b Tetanus Toxoid Conjugate Vaccine, in Healthy Adult Volunteers
    Kim, Namhee
    Choi, Gyoungjin
    Lim, Chi-Yeon
    Lee, Jae-Won
    Kim, Kyung-Hyo
    Lee, Hoan Jong
    ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (06) : 919 - 924
  • [26] Safety and Immunogenicity of the Live Attenuated Varicella Vaccine in Vietnamese Children Aged 12 Months to 12 Years: An Open-Label, Single-Arm Bridging Study
    Hung, Pham Van
    Giang, Le Thi Huong
    Toi, Phung Lam
    Thuc, Vu Thi Minh
    Anh, Bui Dang The
    Pho, Dinh Cong
    Hung, Pham Ngoc
    VIRUSES-BASEL, 2024, 16 (06):
  • [27] Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
    Deng, Li-Juan
    Zhou, Ke-Shu
    Liu, Li-Hong
    Zhang, Ming-Zhi
    Li, Zhi-Ming
    Ji, Chun-Yan
    Xu, Wei
    Liu, Ting
    Xu, Bing
    Wang, Xin
    Gao, Su-Jun
    Zhang, Hui-Lai
    Hu, Yu
    Li, Yan
    Cheng, Ying
    Yang, Hai-Yan
    Cao, Jun-Ning
    Zhu, Zun-Min
    Hu, Jian-Da
    Zhang, Wei
    Jing, Hong-Mei
    Ding, Kai-Yang
    Zhang, Xiang-Yang
    Zhao, Ren -Bin
    Zhang, Bin
    Tian, Ya -Min
    Song, Yong-Ping
    Song, Yu-Qin
    Zhu, Jun
    BLOOD ADVANCES, 2023, 7 (16) : 4349 - 4357
  • [28] A Single-Arm, Open-Label Phase 2 Pilot Study of Vyxeos (CPX-351) in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia
    Shah, Bijal D.
    Rozario, Nicole
    Turba, Elyce P.
    Bello, Celeste
    Chavez, Julio C.
    Sokol, Lubomir
    Brayer, Jason
    Lancet, Jeffrey E.
    BLOOD, 2021, 138
  • [29] A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers
    Karpecki, Paul M.
    Weiss, Sidney L.
    Kramer, William G.
    O'Connor, Patrick
    Evans, David
    Johnston, Josh
    Jasper, April L.
    Justice, Angela
    Ogundele, Abayomi B.
    Devries, Doug
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 591 - 596
  • [30] Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron Variant
    Butt, Adeel A.
    Talisa, Victor B.
    Shaikh, Obaid S.
    Omer, Saad B.
    Mayr, Florian B.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (12) : 2161 - 2168